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Microglia, the resident innate immune cells of the brain, respond to various environmental stimuli, 
including factors from surrounding tissue and from systemic inputs. These stimuli impact microglial 
function in both health and disease. Increasing evidence implicates microglia and neuroinflammation in 
Gulf War illness (GWI) pathology. Gulf War illness is an untreatable chronic multi symptomatic disorder 
that affects about 30% of Gulf War veterans. It has been proposed that “multiple hits” from exposure to 
various environmental neurotoxicants such as Chlorpyrifos (CPF), an organophosphate pesticide, 
combined with low inflammation may initiate exaggerated and persistent central nervous system (CNS) 
pathology to drive GWI.  CPF oxon, an active metabolite of CPF, is associated with deleterious CNS effects, 
but the role of microglia behind this phenomenon is not fully understood.To investigate the effects of CPF 
oxon on microglia, we assessed microglial ROS, pro-inflammatory cytokine factors, and NF-κB p50 DNA 
binding activity in the presence of CPF oxon.  HAPI microglia cells were treated with CPF oxon (1µM-1nM), 
which resulted in a dose dependent increase in H2O2 production at 3 hours and elevated superoxide at 30 
minutes.  CPF oxon failed to initiate TNFα and nitric oxide from microglia cultures.  However, CPF oxon 
significantly decreased NF-κB p50 binding to DNA in microglia, a key redox signaling mechanism linked to 
microglial priming. Consistent with this premise, pre-treatment with CPF oxon (0.5µM) amplified LPS-
induced TNFα production in microglia and neuron-glia cultures. Moreover, when CPF oxon and LPS 
challenged cells were pre-treated with DPI, a NOX2 inhibitor, we found a significant reduction in TNFα 
response when compared to non-treated cells, supporting that NOX2 may regulate CPF oxon priming in 
microglia. These data suggest that CPF oxon may induce ROS production in microglia to reprogram these 
cells to become more sensitive to pro-inflammatory stimuli (priming). 
 
